<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00610558</url>
  </required_header>
  <id_info>
    <org_study_id>UCI-HS-2003-3252</org_study_id>
    <secondary_id>VA-821/103</secondary_id>
    <nct_id>NCT00610558</nct_id>
  </id_info>
  <brief_title>Neocortical Epilepsies - Do They Progress?</brief_title>
  <official_title>Neocortical Epilepsies - Do They Progress?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will use MRI and PET scan to compare the brain imaging results between epilepsy
      patients and normal healthy controls, also to study changes in 3 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We would like to continue analyzing the structural and metabolic differences between two
      epilepsy groups (JME and FLE) and the control to understand the imaging presentations of
      epilepsy patients
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three different Groups in this study: Juvenile Myoclonic Epilepsy, Frontal Lobe Epilepsy, Normal Controls</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Connectivity</measure>
    <time_frame>During Imaging Session</time_frame>
    <description>We will analyze the structural and metabolic differences between two epilepsy groups (JME and FLE) and understand the imaging presentations of epilepsy patients. We will process imaging requisition for Arm 1 and Arm 2 patients and the controls to examine if any differences in their brain image. The hypothesis is the functional connectivity between brainstem structures and cortical/subcortical regions may reflect in their imaging data. We would like to know if these imaging factors are related to epilepsy (JME and FLE) patients.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Arm 1: Juvenile Myoclonic Epilepsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Juvenile Myoclonic Epilepsy group of subjects will participate for imaging assessment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: Frontal Lobe Epilepsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frontal Lobe Epilepsy group of subjects will participate for imaging assessment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3: Normal Controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal Controls, eligible subjects don't have Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy will be placed in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arm 1: Juvenile Myoclonic Epilepsy</intervention_name>
    <description>Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI</description>
    <arm_group_label>Arm 1: Juvenile Myoclonic Epilepsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arm 2: Frontal Lobe Epilepsy</intervention_name>
    <description>Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI</description>
    <arm_group_label>Arm 2: Frontal Lobe Epilepsy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arm 3: Normal Controls</intervention_name>
    <description>Positron emission tomography (PET) fluorodeoxyglucose (FDG) (10 mCi) and MRI</description>
    <arm_group_label>Arm 3: Normal Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Controls (20 Subjects):

        Inclusion criteria:

          -  Ages 18-65, based on the usual ages of patients seen in the adult neurology services
             who are not likely to suffer from the exclusions (see below).

        Exclusion criteria:

          -  History of seizures, faints, or any unexplained blackouts.

          -  Use of neuroleptic medications or sedating doses of antianxiety or antidepressant
             drugs.

          -  They should not have a clear family history of epilepsy (first degree relatives).

          -  History of any substance abuse within the past 5 years.

          -  History of progressive medical or neurologic disease (Parkinson's, severe congestive
             heart failure). Controlled hypertension, diabetes (by oral medications or diet),
             asthma, etc will not be excluded.

          -  History of stroke without complete recovery of neurologic function.

          -  Pregnancy

          -  With any metallic implants, including surgical clips (hemostatic clips), pacemakers,
             neuro-stimulation devices, prosthetic heart valves, or other ferromagnetic material.

          -  Inability to understand the consent. (standard form attached)

          -  Inability to speak fluent English. Note: the neuropsychological tests are standardized
             for English speakers. They are not all available in multiple languages. Since the
             scoring and norms are established for English speakers, simply translating them would
             still not make the testing norms and scoring applicable.

        Juvenile Myoclonic Epilepsy (JME; 20 Subjects):

        Inclusion Criteria:

          -  Ages 18-65, based on the usual ages of patients seen in the adult neurology services
             who are not likely to suffer from the exclusions (see below), plus

          -  History of myoclonic plus tonic-clonic or clonic-tonic-clonic seizures with or without
             absence seizures.

          -  EEG consistent with primary generalized epilepsy (&gt;/= 3 c/s generalized, frontal
             maximum, poly spike and wave; normal alpha)

        Exclusion Criteria

          -  History of significant head injury (&gt; 30 min loss of consciousness)

          -  Use of neuroleptic drugs or sedative doses of antianxiety or antidepressant drugs

          -  History of any substance abuse within the past 5 years

          -  Presence of epileptogenic brain lesion on MRI (tumor, stroke, cortical congenital
             dysplasia, etc; excluding normal variants, mild subcortical white matter ischemic
             change, venous angiomas).

          -  EEG with focal epileptiform potentials or polymorphic slowing

          -  History of progressive medical or neurologic disease (Parkinson's, severe congestive
             heart failure). Controlled hypertension, diabetes (by oral medications or diet),
             asthma, etc will not be excluded.

          -  History of stroke without complete recovery of neurologic function.

          -  Pregnancy

          -  With any metallic implants, including surgical clips (hemostatic clips), pacemakers,
             neuro-stimulation devices, prosthetic heart valves, or other ferromagnetic material.

          -  Inability to speak fluent English

        Frontal Lobe Epilepsy (FLE; 20 Subjects):

        Inclusion Criteria

          -  Ages 18-65, based on the usual ages of patients seen in the adult neurology services
             who are not likely to suffer from the exclusions (see below), plus:

          -  Seizure semiology (behavior) consistent with FLE

          -  Interictal EEG spikes consistent with FLE or

          -  Ictal video-EEG consistent with FLE

          -  Frontal lobe lesion of MRI

          -  Frontal hypometabolism on FDG-PET

        Exclusion Criteria:

          -  Presence of seizure semiology, ictal EEG, interictal EEG, MRI or PET findings that are
             not consistent with a frontal lobe epilepsy focus.

          -  Use of neuroleptic drugs or sedative doses of antianxiety or antidepressant drugs

          -  History of any substance abuse within the past 5 years

          -  History of progressive medical or neurologic disease (Parkinson's, severe congestive
             heart failure). Controlled hypertension, diabetes (by oral medications or diet),
             asthma, etc will not be excluded.

          -  History of stroke without complete recovery of neurologic function.

          -  Pregnancy

          -  With any metallic implants, including surgical clips (hemostatic clips), pacemakers,
             neuro-stimulation devices, prosthetic heart valves, or other ferromagnetic material.

          -  Absence of either a radial or ulnar arterial pulse

          -  Inability to speak fluent English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min-Ying Su, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Functional Onco-Imaging, University of California</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>January 12, 2008</study_first_submitted>
  <study_first_submitted_qc>January 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2008</study_first_posted>
  <results_first_submitted>October 28, 2016</results_first_submitted>
  <results_first_submitted_qc>November 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 20, 2019</results_first_posted>
  <last_update_submitted>November 1, 2019</last_update_submitted>
  <last_update_submitted_qc>November 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Min-Ying (Lydia) Su</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>There is no pre-assignment for this study</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: Juvenile Myoclonic Epilepsy</title>
          <description>Subjects who are eligible for this group will participate MRI imaging</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: Frontal Lobe Epilepsy</title>
          <description>Subjects who are eligible for this group will participate MRI imaging</description>
        </group>
        <group group_id="P3">
          <title>Arm 3: Normal Cont</title>
          <description>Subjects who are eligible for this group will participate MRI imaging</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The imaging data of Arm 3 will be the baseline to compare the difference to the imaging data in Arm 1 and Arm 2. We used an MRI-based with high angular resolution imaging examination of adult human brains. We compared the connectivity patterns in control subjects versus patients with Juvenile Myoclonic Epilepsy or Frontal Lobe Epilepsy,</population>
      <group_list>
        <group group_id="B1">
          <title>Arm1: Juvenile Myoclonic Epilepsy</title>
          <description>Subject will are eligible for this group will participate the MRI imaging</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: Frontal Lobe Epilepsy</title>
          <description>Subject will are eligible for this group will participate the MRI imaging</description>
        </group>
        <group group_id="B3">
          <title>Arm 3: Normal Controls</title>
          <description>Subject will are eligible for this group will participate the MRI imaging</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="14"/>
            <count group_id="B4" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38" spread="6.5"/>
                    <measurement group_id="B2" value="37" spread="6.8"/>
                    <measurement group_id="B3" value="40" spread="7.7"/>
                    <measurement group_id="B4" value="38.3" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Functional Connectivity</title>
        <description>We will analyze the structural and metabolic differences between two epilepsy groups (JME and FLE) and understand the imaging presentations of epilepsy patients. We will process imaging requisition for Arm 1 and Arm 2 patients and the controls to examine if any differences in their brain image. The hypothesis is the functional connectivity between brainstem structures and cortical/subcortical regions may reflect in their imaging data. We would like to know if these imaging factors are related to epilepsy (JME and FLE) patients.</description>
        <time_frame>During Imaging Session</time_frame>
        <population>This protocol has been closed about 10 years ago. All files have been destroyed per IRB requirement.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Juvenile Myoclonic Epilepsy</title>
            <description>Subjects who are eligible to Juvenile Myoclonic Epilepsy will participate the imaging study</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Frontal Lobe Epilepsy</title>
            <description>Subjects who are eligible to Frontal Lobe Epilepsy will participate the imaging study</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Normal Controls</title>
            <description>Subjects who are eligible to the control group will participate the imaging study</description>
          </group>
        </group_list>
        <measure>
          <title>Functional Connectivity</title>
          <description>We will analyze the structural and metabolic differences between two epilepsy groups (JME and FLE) and understand the imaging presentations of epilepsy patients. We will process imaging requisition for Arm 1 and Arm 2 patients and the controls to examine if any differences in their brain image. The hypothesis is the functional connectivity between brainstem structures and cortical/subcortical regions may reflect in their imaging data. We would like to know if these imaging factors are related to epilepsy (JME and FLE) patients.</description>
          <population>This protocol has been closed about 10 years ago. All files have been destroyed per IRB requirement.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects monitored for safety events during the entire imaging session; up to 1 hour</time_frame>
      <desc>All-Cause Mortality, Serious, and non-serious Adverse Events were monitored/assessed, but none observed</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: Juvenile Myoclonic Epilepsy</title>
          <description>15 Subjects were monitored/assessed, but none observed</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Frontal Lobe Epilepsy</title>
          <description>14 Subjects were monitored/assessed, but none observed</description>
        </group>
        <group group_id="E3">
          <title>Arm 3: Normal Controls</title>
          <description>14 Subjects were monitored/assessed, but none observed</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reactions to the contrasts</sub_title>
                <description>Allergic reactions to the radiopharmaceutical may occur, but are extremely rare.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding, soreness or swelling of injection site</sub_title>
                <description>Bleeding, soreness or swelling may develop at injection site.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lydia Su</name_or_title>
      <organization>University of California, Irvine</organization>
      <phone>(949) 824-4925</phone>
      <email>msu@uci.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

